OnKure Therapeutics, Inc.
OKUR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $115 | $221 | $311 | $155 |
| - Cash | $111 | $30 | $12 | $125 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $5 | $192 | $300 | $30 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$52 | -$35 | -$29 | -$40 |
| % Margin | – | – | – | – |
| Net Income | -$53 | -$35 | -$30 | -$40 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.95 | -2.65 | -2.21 | -21.92 |
| % Growth | -49.1% | -19.9% | 89.9% | – |
| Operating Cash Flow | -$51 | -$35 | -$27 | -$38 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$51 | -$35 | -$28 | -$38 |